Zaprinast

Zaprinast is an agonist of GPR and PDE used in studies of GPCR Signaling. It is especially relevant in cardiovascular, cell signaling, and neuroscience models, where defined compound exposure can be linked to receptor-driven second-messenger signaling and desensitization dynamics.

By activating GPR and PDE, Zaprinast can be used to examine receptor-driven second-messenger signaling and desensitization dynamics. The gpcr annotation adds relevance to GPCR pharmacology, ligand-binding, and signaling assays, together with downstream-response mapping in the same experimental setting. In cardiovascular, cell signaling, and neuroscience models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving GPR and PDE
• Pathway perturbation studies connected to GPCR Signaling
• Agonist-response and downstream signaling studies
• GPCR pharmacology, ligand-binding, and signaling assays

Overall, Zaprinast is appropriate when a defined chemical perturbant is needed to connect GPR and PDE with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cardiovascular, cell signaling, and neuroscience models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.